ARK offers fully transparent ETFs and discloses intra-day trades for the ARKK ETF. Files of intra-day trades are not provided until full trade execution (with reasonable time to post). Click here to see intra-day trades of the current day.
The principal risks of investing in ARK’s actively managed ARKK ETF include equity, market, management, concentration and non-diversification risks, as well as fluctuations in market value and net asset value (“NAV”). The principal risks of investing in ARKK: Equity Securities Risk. The value of the equity securities the Fund holds may fall due to general market and economic conditions. Foreign Securities Risk. Investments in the securities of foreign issuers involve risks beyond those associated with investments in U.S. securities. Health Care Sector Risk.
The health care sector may be adversely affected by government regulations and government health care programs. Industrials Sector Risk. Companies in the industrials sector may be adversely affected by changes in government regulation, world events, economic conditions, environmental damages, product liability claims and exchange rates. Information Technology Sector Risk. Information technology companies face intense competition, both domestically and internationally, which may have an adverse effect on profit margins.
Portfolio holdings will change and should not be considered as investment advice or a recommendation to buy, sell or hold any particular security.
 Source: ARK Investment Management LLC, Research
ARKK Full Description:
Genomic Revolution: Companies that are substantially focused on and are expected to substantially benefit from extending and enhancing the quality of human and other life by incorporating technological and scientific developments, improvements and advancements in genomics into their business, such as by offering new products or services that rely on genomic sequencing, analysis, synthesis or instrumentation. These companies may be from multiple sectors (such as health care, information technology, materials, energy or consumer discretionary) and may include companies that develop, produce, manufacture or significantly rely on or enable bionic devices, bio-inspired computing, bioinformatics, molecular medicine, and agricultural biotechnology.
Industrial Innovation: Companies that are expected to focus on and benefit from the development of new products or services, technological improvements and advancements in scientific research related to, among other things, disruptive innovation in energy (i.e. storage, collection or implementation of new sources, production or development of new materials), automation and manufacturing (i.e. productivity of machines, automation of functions, processes or other activities, or the use of robotics to perform other functions, activities or processes), materials, and transportation.
Web x.0: Companies that are focused on and expected to benefit from shifting the bases of technology infrastructure from hardware and software to the cloud, enabling mobile and local services, such as companies that rely on or benefit from the increased use of shared technology, infrastructure and services. These companies may also include ones that develop, use or rely on innovative payment methodologies, big data, the internet of things, and social distribution and media.